Table 3.
Men |
Women |
|||
---|---|---|---|---|
Characteristic | Unadjusted, odds ratio (95% CI) |
Multivariate,* odds ratio (95% CI) |
Unadjusted, odds ratio (95% CI) |
Multivariate,** odds ratio (95% CI) |
Age, yr | ||||
| ||||
30–49 | 4.26 (2.33–7.81) | 3.25 (1.81–5.84) | 3.53 (2.26– 5.54) |
2.34 (1.46– 3.75) |
50–64 | 2.25 (1.30–3.91) | 2.45 (1.31–4.57) | 1.38 (0.85– 2.25) |
1.15 (0.69– 1.89) |
≥65 | 2.53 (0.99–6.47) | 1.48 (0.69–3.16) | 1.72 (0.90– 3.31) |
1.48 (0.68– 3.23) |
p interaction | 0.266 | 0.630 | 0.013 | 0.030 |
SSRI/SNRI use |
||||
No | 2.54 (1.72–3.76) | 2.10 (1.33–3.33) | 2.00 (1.42– 2.81) |
1.59 (1.09– 2.33) |
Yes | 3.47 (1.43–8.41) | 2.66 (1.15–6.16) | 3.40 (1.79– 6.45) |
2.52 (1.31– 4.84) |
p interaction | 0.516 | 0.830 | 0.131 | 0.175 |
Sleep interference |
||||
No | 2.82 (1.63–4.88) | 2.43 (1.41–4.20) | 1.40 (0.95– 2.07) |
1.10 (0.74– 1.64) |
Yes | 1.84 (0.76–4.46) | 2.18 (0.73–6.53) | 4.15 (2.25– 7.67) |
3.37 (1.63– 6.94) |
p interaction | 0.428 | 0.635 | 0.002 | 0.009 |
CI = confidence interval; SSRI/SNRI = selective serotonin reuptake inhibitor/serotonin–norepinephrine reuptake inhibitor.
Adjusted for age, race/ethnicity, socioeconomic status, physical activity, smoking, alcohol consumption, and arthritis.
Adjusted for age race/ethnicity, socioeconomic status, smoking, alcohol consumption, heart disease, and diabetes.